A radioactive medicine used for somatostatin receptor-positive gastroenteropancreatic neeuroendocrine tumors (GEP-NETs). It binds itself to a specific part of certain tumor cells, allowing the radiation to enter and destroy those cells.
(866) 850-9555
help@netcancerawareness.org